These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 870661)

  • 21. Temporal and individual variations in the dose of glucocorticoid used for the treatment of salt-losing congenital virilizing adrenal hyperplasia due to 21-hydroxylase deficiency.
    Sandrini R; Jospe N; Migeon CJ
    Acta Paediatr Suppl; 1993 Mar; 388():56-60; discussion 61. PubMed ID: 8329832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment and disease effects on short-term growth and adult height in children and adolescents with 21-hydroxylase deficiency.
    Hauffa BP; Winter A; Stolecke H
    Klin Padiatr; 1997; 209(2):71-7. PubMed ID: 9113619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth pattern of untreated boys with simple virilizing congenital adrenal hyperplasia indicates relative androgen insensitivity during the first six months of life.
    Bonfig W; Schwarz HP
    Horm Res Paediatr; 2011; 75(4):264-8. PubMed ID: 21196707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term effects of aminoglutethimide on steroid metabolism in congenital adrenal hyperplasia.
    Hamilton W
    Clin Chim Acta; 1976 Nov; 73(1):135-8. PubMed ID: 1000823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Puberty and growth development in patients with a 21-hydroxylase defect].
    Börger D; Willig RP
    Monatsschr Kinderheilkd; 1985 Nov; 133(11):828-33. PubMed ID: 2934617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Congenital adrenal hyperplasia: renin and steroid values during treatment.
    Grant DB; Dillon MJ; Atherden SM; Levinsky RJ
    Eur J Pediatr; 1977 Aug; 126(1-2):86-96. PubMed ID: 902665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dehydroepiandrosterone sulfate (DS) levels, a rapid test for abnormal adrenal androgen secretion.
    Korth-Schutz S; Levine LS; New MI
    J Clin Endocrinol Metab; 1976 Jun; 42(6):1005-13. PubMed ID: 180041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth inhibition by glucocorticoid treatment in salt wasting 21-hydroxylase deficiency: in early infancy and (pre)puberty.
    Stikkelbroeck NM; Van't Hof-Grootenboer BA; Hermus AR; Otten BJ; Van't Hof MA
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3525-30. PubMed ID: 12915631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis and management of congenital adrenal hyperplasia.
    Migeon CJ
    Hosp Pract; 1977 Mar; 12(3):75-82. PubMed ID: 190110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood testosterone values in patients with congenital virilizing adrenal hyperplasia.
    Solomon IL; Schoen EJ; Donelan L; Brandt-Erichsen D
    J Clin Endocrinol Metab; 1975 Mar; 40(3):355-62. PubMed ID: 163840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gonadotropin output in congenital adrenal hyperplasia before and after adrenal suppression.
    Klingensmith GJ; Wentz AC; Meyer WJ; Migeon CJ
    J Clin Endocrinol Metab; 1976 Oct; 43(4):933-6. PubMed ID: 185235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Medroxyprogesterone acetate. Contributive treatment in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in children].
    La Selve H; Sempé M; Morel Y; Forest MG; de Peretti E; David M
    Arch Fr Pediatr; 1985; 42(7):511-6. PubMed ID: 2935112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydrocortisone dosing during puberty in patients with classical congenital adrenal hyperplasia: an evidence-based recommendation.
    Bonfig W; Pozza SB; Schmidt H; Pagel P; Knorr D; Schwarz HP
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3882-8. PubMed ID: 19622620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CONGENITAL ADRENAL HYPERPLASIA.
    RAITI S; NEWNS GH
    Arch Dis Child; 1964 Aug; 39(206):324-33. PubMed ID: 14206872
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of congenital virilizing adrenal hyperplasia patients with single and multiple daily doses of prednisone.
    Huseman CA; Varma MM; Blizzard RM; Johanson A
    J Pediatr; 1977 Apr; 90(4):538-42. PubMed ID: 839364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamics of adrenal steroidogenesis in childhood: changes in the excretion of 16-oxygenated- and 11-oxygenated-steroids by 21-hydroxylase deficient children at various ages.
    Kecskés L
    Endokrinologie; 1982 Oct; 80(2):151-7. PubMed ID: 6297879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identical male twins with congenital adrenal hyperplasia. Comparison of growth, serum and urinary steroids.
    Connors MH; Sheikholislam BM
    West J Med; 1976 Apr; 124(4):335-8. PubMed ID: 1266219
    [No Abstract]   [Full Text] [Related]  

  • 38. Management of congenital adrenal hyperplasia using serum dehydroepiandrosterone sulfate and 17-hydroxyprogesterone concentrations.
    Golden MP; Lippe BM; Kaplan SA; Lavin N; Slavin J
    Pediatrics; 1978 Jun; 61(6):867-71. PubMed ID: 149950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adult height in women with early-treated congenital adrenal hyperplasia (21-hydroxylase type): relation to body mass index in earlier childhood.
    Yu AC; Grant DB
    Acta Paediatr; 1995 Aug; 84(8):899-903. PubMed ID: 7488814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The urinary steroidome of treated children with classic 21-hydroxylase deficiency.
    Kamrath C; Wettstaedt L; Boettcher C; Hartmann MF; Wudy SA
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):396-406. PubMed ID: 27544322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.